A company focused on the oncology therapeutic area, connecting physicians and patients
Investors 1
| Date | Name | Website |
| 10.07.2026 | Qiming Ven... | qimingvc.c... |
Mentions in press and media 1
| Date | Title | Description |
| 16.05.2022 | Antengene Announces Commercial Availability of XPOVIO® (Selinexor), for the Treatment of Relapsed/Refractory Multiple Myeloma, Prescribed for the First Time Across Mainland China | -Distribution channels in place to streamline/facilitate patient access. -XPOVIO® will be available in 600 hospitals and 105 DTPs (across China including Beijing, Shanghai, Guangdong, Jiangsu, Zhejiang, Henan, and Shandong). SHANGHAI and HO... |